Upload
step
View
31
Download
0
Tags:
Embed Size (px)
DESCRIPTION
University of Rome “Sapienza” Department of Thoracic Surgery. WHAT SHOULD CHANGE IN LUNG CANCER STAGING. AIMS of TNM. Use the same language worldwhile Pool patients with similar disease Differentiate prognosis and treatment Avoid overlapping prognosis Compare data worldwide. HISTORY. - PowerPoint PPT Presentation
Citation preview
University of Rome “Sapienza”University of Rome “Sapienza”Department of Thoracic SurgeryDepartment of Thoracic Surgery
WHAT SHOULD WHAT SHOULD CHANGE IN LUNG CHANGE IN LUNG CANCER STAGINGCANCER STAGING
AIMS of TNMAIMS of TNM
• Use the same language worldwhileUse the same language worldwhile• Pool patients with similar diseasePool patients with similar disease• Differentiate prognosis and treatmentDifferentiate prognosis and treatment• Avoid overlapping prognosisAvoid overlapping prognosis• Compare data worldwideCompare data worldwide
HISTORYHISTORY
• 19461946 Union Internationale Contre Cancer (UICC) TNM System Union Internationale Contre Cancer (UICC) TNM System
• 1959 1959 American Joint Commette for Cancer (AJCC) StagingAmerican Joint Commette for Cancer (AJCC) Staging
• 1966 1966 UICC TNM and StagingUICC TNM and Staging
• 19741974 UICC e AJCC UICC e AJCC
• 19861986 International Staging System UICC e AJCC (IV Internat. International Staging System UICC e AJCC (IV Internat.
Congr. Lung Ca.) MountainCongr. Lung Ca.) Mountain
• 1997 1997 Revision of the International Staging System of Lung Revision of the International Staging System of Lung
Cancer. Mountain CF. Chest 1997; 111:1710-17Cancer. Mountain CF. Chest 1997; 111:1710-17
• 20092009 The hypothetical next… The hypothetical next…
WHERE WE AREWHERE WE ARE
WHERE WE AREWHERE WE ARE
• 00 Carcinoma in situCarcinoma in situ• IAIA T1N0M0T1N0M0• IBIB T2N0M0T2N0M0• IIAIIA T1N1M0T1N1M0• IIBIIB T2N1M0, T3N0M0T2N1M0, T3N0M0• IIIAIIIA T3N1M0, any N2T3N1M0, any N2• IIIBIIIB Any T4, any N3Any T4, any N3• IVIV Any T and any N M1Any T and any N M1
WHERE WE ARE WHERE WE ARE
WHERE WE AREWHERE WE ARE
HYPOTHESISHYPOTHESIS
• In small-size tumors the diameter is a In small-size tumors the diameter is a prognostic factor? prognostic factor?
• Different prognosis in the same T Different prognosis in the same T factor with different sites of invasion?factor with different sites of invasion?
• How much important is the nodal How much important is the nodal status?status?
• Are other subgroups important in the Are other subgroups important in the N status ?N status ?
OPEN QUESTIONSOPEN QUESTIONS
• T1 Size T1 Size
• T2 larger 5 cm T3 ?T2 larger 5 cm T3 ?
• T3 – T4: Site of invasion T3 – T4: Site of invasion
• T4 satellite – T4 invasionT4 satellite – T4 invasion
• N1: single – multiple; micro – macroN1: single – multiple; micro – macro
T1: SIZE OF THE TUMORT1: SIZE OF THE TUMORLiterature Watch Literature Watch
STAGE IB – IIA STAGE IB – IIA
J. Thorac. Cardiovasc. Surg. Aug 2006;132: 316-9 J. Thorac. Cardiovasc. Surg. Aug 2006;132: 316-9
STAGE IB – IIA STAGE IB – IIA
• Year 1994 only – 6644 Patients Year 1994 only – 6644 Patients • Multicenter retrospective reviewMulticenter retrospective review• T1aT1a ≤ 2 cm ≤ 2 cm • T1b T1b > 2.1 – 3 cm> 2.1 – 3 cm
Now Now Then Then• IA IA T1N0M0T1N0M0 T1aN0M0T1aN0M0• IB IB T2N0M0T2N0M0 T1bN0M0T1bN0M0• IIA IIA T1N1M0T1N1M0 T2N0M0T2N0M0 + T1N1M0 + T1N1M0
STAGE IB – IIA STAGE IB – IIA
J. Thorac. Cardiovasc. Surg. Aug 2006;132: 316-9 J. Thorac. Cardiovasc. Surg. Aug 2006;132: 316-9
CLINICALCLINICAL PATHOLOGICPATHOLOGIC
STAGE IB – IIA STAGE IB – IIA
• Stages IB and IIA merged as new IIAStages IB and IIA merged as new IIA
• Cut-off T1a vs T1b Cut-off T1a vs T1b ≤ 2 cm≤ 2 cmJ. Thorac. Cardiovasc. Surg. Aug 2006;132: 316-9 J. Thorac. Cardiovasc. Surg. Aug 2006;132: 316-9
CLINICALCLINICAL PATHOLOGICPATHOLOGIC
T2 LARGER THAN 5 CM … T3?T2 LARGER THAN 5 CM … T3?
J. Thorac. Cardiovasc. Surg. 2001;122:907-12J. Thorac. Cardiovasc. Surg. 2001;122:907-12
T2 LARGER THAN 5 CM … T3?T2 LARGER THAN 5 CM … T3?
• 545 Patients (T > 3 cm)545 Patients (T > 3 cm)
• Same nodal statusSame nodal status
• 3 Groups (3.1 – 5 cm, 5.1 – 7 cm, > 7 cm)3 Groups (3.1 – 5 cm, 5.1 – 7 cm, > 7 cm)
• T2a T2a ≤ 5 cm vs T2b > 5 cm ≤ 5 cm vs T2b > 5 cm
T2 LARGER THAN 5 CM … T3?T2 LARGER THAN 5 CM … T3?
J. Thorac. Cardiovasc. Surg. 2001;122:907-12J. Thorac. Cardiovasc. Surg. 2001;122:907-12
T2 LARGER THAN 5 CM … T3?T2 LARGER THAN 5 CM … T3?
J. Thorac. Cardiovasc. Surg. 2001;122:907-12J. Thorac. Cardiovasc. Surg. 2001;122:907-12
WHEN THE TUMOR IS LARGER THAN 5 CM THE PROGNOSIS IS THE SAMEWHEN THE TUMOR IS LARGER THAN 5 CM THE PROGNOSIS IS THE SAME
T2 LARGER THAN 5 CM … T3?T2 LARGER THAN 5 CM … T3?
J. Thorac. Cardiovasc. Surg. 2001;122:907-12J. Thorac. Cardiovasc. Surg. 2001;122:907-12
T2 LARGER THAN 5 CM … T3?T2 LARGER THAN 5 CM … T3?
• T2b poorer survival than T2aT2b poorer survival than T2a
• T2b T2b upgradedupgraded to T3 to T3
• Nodal status has addictive effectNodal status has addictive effect
STAGE IIISTAGE III
J. Thorac. Cardiovasc. Surg. 2002;124:503-10J. Thorac. Cardiovasc. Surg. 2002;124:503-10
• Overall 429 PatientsOverall 429 Patients• 73 IIIA and 79 IIIB73 IIIA and 79 IIIB
STAGE IIISTAGE III
J. Thorac. Cardiovasc. Surg. 2002;124:503-10J. Thorac. Cardiovasc. Surg. 2002;124:503-10
IN THIS SERIESIN THIS SERIES no difference in survival between IIIA and IIIB no difference in survival between IIIA and IIIB
STAGE IIISTAGE III
J. Thorac. Cardiovasc. Surg. 2002;124:503-10J. Thorac. Cardiovasc. Surg. 2002;124:503-10
IN THIS SERIESIN THIS SERIES no difference in survival between T3 and T4 no difference in survival between T3 and T4
STAGE IIISTAGE III
Overall 429 PatientsOverall 429 Patients73 IIIA and 79 IIIB73 IIIA and 79 IIIB
• T3 bronchial vs T3 extrapulmonaryT3 bronchial vs T3 extrapulmonary• T4 tracheal, T4 satellite, T4 T4 tracheal, T4 satellite, T4
extrapulmonary, T4 malignant exudateextrapulmonary, T4 malignant exudate• Complete surgical resection for T3Complete surgical resection for T3• R0 resections for T4R0 resections for T4
STAGE IIISTAGE III
J. Thorac. Cardiovasc. Surg. 2002;124:503-10J. Thorac. Cardiovasc. Surg. 2002;124:503-10
T3T3 T4T4
STAGE IIISTAGE III
T3 BRONCHIAL T3 BRONCHIAL
T2T2
T4 SATELLITE & TRACHEAL T4 SATELLITE & TRACHEAL
T3T3
RECLASSIFICATIONRECLASSIFICATION
J. Thorac. Cardiovasc. Surg. 2002;124:503-10J. Thorac. Cardiovasc. Surg. 2002;124:503-10
STAGE III STAGE III
• T3 bronchial downstaged to T2T3 bronchial downstaged to T2
• T4 tracheal and satellite downstaged to T3T4 tracheal and satellite downstaged to T3
• Better survival for R0 T3 and T4Better survival for R0 T3 and T4
• Surgical curativity should be taken into Surgical curativity should be taken into account in the reevaluation of staging account in the reevaluation of staging
T4 SATELLITE vs INVASIONT4 SATELLITE vs INVASION
Ann. Thorac. Surg.2006;82:1808-14Ann. Thorac. Surg.2006;82:1808-14
T4 SATELLITE vs INVASIONT4 SATELLITE vs INVASION
• Overall 337 PatientsOverall 337 Patients
• T4N0M0 Satellite (n=26)T4N0M0 Satellite (n=26)
• T4N0M0 Invasion (n=25)T4N0M0 Invasion (n=25)
• T4 pleural effusion excludedT4 pleural effusion excluded
T4 SATELLITE vs INVASIONT4 SATELLITE vs INVASION
Ann. Thorac. Surg.2006;82:1808-14Ann. Thorac. Surg.2006;82:1808-14
N0N0
T4 SATELLITE vs INVASIONT4 SATELLITE vs INVASION
Ann. Thorac. Surg.2006;82:1808-14Ann. Thorac. Surg.2006;82:1808-14
PET UPTAKE!!!!!PET UPTAKE!!!!!
T4 SATELLITE vs INVASIONT4 SATELLITE vs INVASION
• Separation of heterogeneous types of T4Separation of heterogeneous types of T4• T4N0M0 Satellite should be downstagedT4N0M0 Satellite should be downstaged• MaxSUV should be taken into account as best MaxSUV should be taken into account as best
predictor predictor
N1 INVOLVEMENTN1 INVOLVEMENT
Lung Cancer 2004;43:151-7Lung Cancer 2004;43:151-7
N1 INVOLVEMENTN1 INVOLVEMENT
Lung Cancer 2004;43:151-7Lung Cancer 2004;43:151-7
N1 SINGLE vs MULTIPLEN1 SINGLE vs MULTIPLE
Lung Cancer 2004;43:151-7Lung Cancer 2004;43:151-7
N1 MICRO vs MACRON1 MICRO vs MACRO
Lung Cancer 2004;43:151-7Lung Cancer 2004;43:151-7
N1 INVOLVEMENTN1 INVOLVEMENT
• Micro and single-node N1 downstaged Micro and single-node N1 downstaged respect macro and multiple-node N1respect macro and multiple-node N1
• Different therapeutic approaches for Different therapeutic approaches for subgroups subgroups
FUTUREFUTURE
FUTUREFUTURE
FUTUREFUTURE
WHERE ARE WE GOING?WHERE ARE WE GOING?
• It is necessary new staging (2009?)It is necessary new staging (2009?)
• T factor is a good targetT factor is a good target
• MaxSUV could be a better survival MaxSUV could be a better survival predictor than TNM predictor than TNM
• Genomic studies ??????Genomic studies ??????
• Long-term survival is affected not only by Long-term survival is affected not only by staging but first of all by treatment…staging but first of all by treatment…